Nature子刊：最高保护效力超90%，RSV疫苗迎来里程碑式批准
Time：
2023-06-14 09:28
Author：
xieyijun
本文系陆金华博士在“首届（张江）国际生物工艺与工程大会”中报告整理
Time：
2023-06-12 09:31
Author：
xieyijun
被FDA抛弃的百亿市值Biotech：成也PARPi，败也PARPi
Time：
2023-06-10 09:41
Author：
xieyijun
2023年美国临床肿瘤学会（ASCO）年会将于美国中部夏令时间6月2日至6日在美国芝加哥举行。
Time：
2023-06-07 16:51
Author：
程广庆
本文系清华大学医院管理研究院教授兼研究员陈怡老师在“扬州生物医药论坛”上做的报告内容整理。
Time：
2023-06-07 13:27
Author：
xieyijun
Recommended content
WCLC 2026 | Hansun "Blows the Roof Off", the New King of B7-H3 ADC is About to be Crowned
It's time for Chinese innovative drugs to redefine the standards.
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务